Immune Thrombocytopenia Market Economic Impact, Dynamics and SWOT Analysis Till 2030

 

Immune Thrombocytopenia Market Overview

Immune thrombocytopenia (ITP) is a disorder that refers to improper blood-clotting and its rising prevalence suggests that a tentative 5.78% CAGR is quite possible for the global immune thrombocytopenia market during the forecast period (2020-2027) and a scaling of USD 2,300 Mn seems achievable. The disease causes a drop in platelet count which ends in bruising and bleeding. It can occur in both adults and children. The disease can get triggered by other diseases such as autoimmune diseases, medications, chronic infections, pregnancy and certain type of cancers.

Market Research Future (MRFR) reveals that the Immune Thrombocytopenia Market can expect much better positioning owing to the growing demand for drugs and therapeutics for ITP. At the same time, countries are focusing much on research and development and the investment in the sector has increased considerably. Treatment facilities have also surged in numbers bolstering the growth of the immune thrombocytopenia market.     

The risk of immune thrombocytopenia is higher in people having antiphospholipid syndrome, lupus, and rheumatoid arthritis. Immune thrombocytopenia can result in small reddish-purple dots which appear as a rash or purple bruise. It may have no symptoms, but when it occurs it may include excessively heavy menstrual flow, blood in stools/urine, excessive or easy bruising, bleeding from nose or gums, and superficial bleeding in the skin which appear as reddish-purple spots that are pinpoint-sized and appear as a rash, generally on the lower legs.

Immune Thrombocytopenia Market Segmentation

MRFR’s segmental analysis of the segmental analysis of the global ITP market is based on type, treatment, and end-user. The in-depth analysis would reveal the changing scenario of the market with both volume-wise and value-wise data.

Based on the type, the immune thrombocytopenia market includes chronic immune thrombocytopenia and acute immune thrombocytopenia. As per reports of 2017, the chronic immune thrombocytopenia segment had around 85% of the global market share. The segment is anticipating a CAGR of 5.94%to exceed a valuation of USD 2,036.9 Mn during the forecast period.

Based on the treatment, the immune thrombocytopenia market comprises intravenous immunoglobulins, thrombopoietin receptor agonists, corticosteroids, and others. Records of 2017 suggests that, value-wise, the corticosteroids segmented had 40% of the market under its wings share of the global ITP market. The segment is expected to attain a CAGR of 5.57% over the review period. Its popularity grows with its prolific use as steroid hormones in ITP therapies.

Based on the end-user, the immune thrombocytopenia market consists research & academic institutes, specialty centers, hospitals & clinics, and others. The hospitals & clinic segment has around 38% market share and is projected to witness a CAGR of 6.22% during the forecast period.

 Regional Analysis:

Geographical analysis of the global ITP market, as conducted by MRFR, includes the Americas, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA).

With a market reach of over 43.3%, the Americas is the dominating region and it is going to helm the market during the assessment period. The prevalence of the disease is growing higher and along with it, options of developing better cure. These features have been further backed by robust reimbursement policies. Such features have created substantial scope for the market to expand.

Europe is holding the second position. The market in Europe has similar features like that of the Americas owing to which the growth in the coming years would be intense. Other factors such as increasing funding in the research and development sector can be taken into consideration while measuring market possibilities.

The APAC market is quite promising. The rate of growing awareness is quite high and revamping healthcare sectors in emerging economies are providing much scope for expansion. The regional market has also emerged as lucrative option for foreign players which is why its growth rate in the coming years would be astonishing.

Competitive Landscape:

Players profiled by MRFR for their remarkable contribution in the immune thrombocytopenia market Players are CSL Limited, Amgen Inc., F.Hoffmann-La Roche Ltd., Dova Pharmaceuticals, Kyowa Hakko Kirin Co., Ltd., Jiangsu Hengrui Pharmaceutical Co., Ltd., Novartis AG, Ligand Pharmaceuticals, Inc., Shire, Rigel Pharmaceuticals, Inc., and Shionogi Inc.

The American Society of Hematology published an article in 2019 where low-dose chidamide is said to hold ability to restore immune tolerance in immune thrombocytopenia. It performs by starting a modulation of natural Treg cells and CTLA4 gene expression. The published article points at a potentiality of the drug in countering ITP in clinics. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

 


Comments

Post a Comment

Popular posts from this blog

Chronic Obstructive Pulmonary Disease Treatment Market Trends, Overview, Competitors Strategy, Regional Analysis and Growth Foresight 2030

Image
  Chronic Obstructive Pulmonary Disease Treatment Market Overview The global market report on chronic obstructive pulmonary disease has the potential to capitalize on various factors that have a link with unhealthy lifestyle or pollution and others. Due to this unhealthy lifestyle, many people have started smoking, which can directly influence various chronic obstructive pulmonary diseases. On the other hand, if people spend their time in places with poor airflow, they can trigger various symptoms of the disease. Pollution can alleviate the symptoms and play a significant role in influencing the increase in number for people suffering from the disease. with the increasing factors like pollution and other unhealthy lifestyles. These factors have been noted by Market Research Future (MRFR) for their elaborate study on the same market.  The Chronic Obstructive Pulmonary Disease Market  Size was valued at USD 1.82 billion in 2021 and is projected to grow from USD 3.07 Billi...
Read more

Dental 3D Printing Market Trend, Size, Growth and Forecast to 2030

Image
  Dental 3D Printing Market Overview Dental 3D printing witnesses extensive demand in the cosmetic dentistry which in turn, escalates its market on the global heights. Considering the kind of the growth, the market perceives currently, Market Research Future (MRFR) in its recently published analysis asserts that the global  Dental 3D Printing Market   will register over 15.61 % CAGR during the review period (2022 – 2030), reaching exponential heights by 2030.  Dental 3D printing is a huge evolution that ever occurred in the dental world. It can perform faster, is cost-competitive, and can offer unique products and services, providing an excellent return on investment. Considered as the form of modern dentistry, dental 3D printing creates three dimensional solid dental models for surgical guides, dentures, dental implants, crown, and bridges. Additional factors substantiating the market growth include the growing prevalence of dental decays and diseases and increa...
Read more

RSV Diagnostics Market Segments, Industry Sales, Profits and Regional Study 2030

Image
  RSV Diagnostics Market Overview The rising incidence rate of respiratory infections has done wonders for the market and is bound to surge at a significant rate in the coming years. with the growth in the incidences of chronic diseases around the world, there is bound to be an increase in the case of respiratory infections. This is going to have a definite positive impact on the demand for testing of infectious diseases like RSV. The deaths among neonates owing to these infections can be prevented when timely diagnosis and subsequent treatment is provided. Thus, the growing awareness regarding this factor is set to enhance the growth of the  RSV Diagnostics Market   in the years ahead. The latest report by Market Research Future (MRFR) states that the Respiratory Syncytial Virus (RSV) market is all set to gain substantial traction by accruing gigantic revenues by 2030. In addition, it is on track to surge at a CAGR of 10.7 % during the forecast period (2022–2030).The d...
Read more